Results 231 to 240 of about 655,147 (306)

Optimization of the β-Aminoester class of factor Xa inhibitors. part 1: P4 and side-Chain modifications for improved In vitro potency

, 2002
Mark Czekaj, Scott I. Klein, Kevin R. Guertin, Charles J. Gardner, Allison L. Zulli, Henry W. Pauls, Alfred P. Spada, Daniel L. Cheney, Karen Brown, Dennis Colussi, Valeria Chu, Robert J. Leadley, Christopher T. Dunwiddie   +12 more
openalex   +1 more source

Factor Xa inhibitors vs. warfarin in patients with Hughes syndrome: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Mohtashim A, Azhar A, Mazhar S, Devi D, Danial M, Patel D, Khan O, Andani A, Khan MM, Samad S, Qureshi A, Ali H, Ejaz U, Jawad S.   +13 more
europepmc   +1 more source

The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis. [PDF]

Circulation
Siegal DM, Forbes N, Eikelboom J, Beyer-Westendorf J, Cohen AT, Xu L, Connolly SJ, Crowther M.   +7 more
europepmc   +1 more source

Discovery ofBAY 3389934 Hydrochloride: A Potent andSelective Small-Molecule Dual Factor IIa/Xa Inhibitor with Short Half-Lifefor the Acute Treatment of Sepsis-Induced Coagulopathy

Hartmut Beck (3076206), Stefanie Mesch (2316391), Stefanie Zimmermann (1906102), Alexandros Vakalopoulos (8659995), Lutz Lehmann (2153491), Kersten Matthias Gericke (14233008), Frank Süßmeier (21526049), Lars Baerfacker (21526052), Alexander Hillisch (1353261), Katharina Meier (2321314), Adrian Tersteegen (9568933), Anja Buchmüller (21526055), Christoph Gerdes (16940570), Julia Dietze-Torres (21526058), Elisabeth Kersten (9473255), Katrin Partikel (21526061), Andreas Bröhl (1763770), Guillaume Levilain (2250391), Stefan Heitmeier (6279803), Nils Pfaff (21526064), Markus Follmann (1585201)   +20 more
openalex   +1 more source

Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study. [PDF]

J Clin Med
Escobar C, Palacios B, Villarreal M, Gutiérrez M, Capel M, Aranda U, Hernández I, García M, Lledó L, Arenillas JF.   +9 more
europepmc   +1 more source

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors

American journal of hematology/oncology, 2012
S. Kaatz, P. Kouides, D. Garcia, A. Spyropolous, M. Crowther, J. Douketis, A. Chan, A. James, S. Moll, T. Ortel, E. V. Van Cott, J. Ansell   +11 more
semanticscholar   +1 more source

Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA-4: Time and Severity Matter Most. [PDF]

Stroke Vasc Interv Neurol
Concha M, Xu L, Horn M, Ohara T, Nakamya J, Beyer-Westendorf J, Shoamanesh A, Cohen A, Ladenvall P, Connolly SJ, Demchuk AM.   +10 more
europepmc   +1 more source

Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study. [PDF]

J Clin Med
Escobar C, Palacios B, Villarreal M, Gutiérrez M, Capel M, Hernández I, García M, Lledó L, Arenillas JF.   +8 more
europepmc   +1 more source

Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjects

, 2009
Xia Zhao, Peihong Sun, Ying Zhou, Yuwang Liu, Huilin Zhang, Wolfgang Mueck, Dagmar Kubitza, Richard Bauer, Hong Zhang, Yimin Cui   +9 more
openalex   +1 more source

Factor Xa inhibitors versus low-molecular-weight heparin for preventing coagulopathy following COVID-19: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Amin L, Qayyum K, Uzair M, Khan F, Sethi P, Hanif L, Azhar A, Mazhar S, Ejaz U, Jawad S.   +9 more
europepmc   +1 more source